Summary & Overview
HCPCS Level II Q4178: Floweramniopatch, Per Square Centimeter
HCPCS Level II code Q4178 designates Floweramniopatch billed per square centimeter as an add-on product used in surgical or procedural settings to support tissue coverage and healing. This code matters nationally because it standardizes reporting for an emerging class of adjunctive biologic products, enabling consistent billing, utilization tracking, and payer review across facilities performing wound, membrane, or graft-related procedures.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for use of the product, common sites of service where the product is applied, and the role of an add-on HCPCS Level II code in claims workflows. The publication summarizes benchmarks where available, highlights relevant policy and coverage themes for major payers, and outlines billing considerations tied to add-on product reporting.
The report provides national-level context for facility and professional billing teams, coding professionals, and policy analysts seeking clarity on documentation expectations, claims submission structure for adjunctive biologic products, and payer coverage patterns. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code Q4178 describes Floweramniopatch, billed per square centimeter as an add-on, list separately in addition to primary procedure. This item represents a biologic or graft product applied to an anatomic site to support healing, typically used in procedures that require adjunctive wound or membrane coverage.
Service Type: Adjunctive biologic graft/product application
Typical Site of Service: Operating room, ambulatory surgical center, or hospital inpatient/surgical setting
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric patient with a persistent ocular surface defect or conjunctival/forniceal wound following pterygium excision, chemical burn, chronic epithelial defect, or conjunctival reconstruction. The treating clinician (ophthalmologist or ocular surface specialist) uses a biologic amniotic membrane graft product, billed as Q4178 per square centimeter as an add-on supply, to promote epithelial healing and reduce inflammation and scarring. The clinical workflow typically includes preoperative assessment of the defect, informed consent, measurement of the area to be grafted, concurrent primary surgical procedure (for example conjunctival autograft, pterygium excision, tarsorrhaphy, or debridement), preparation of the ocular surface, placement and securing of the amniotic membrane graft (sutures, fibrin glue, or bandage contact lens), and postoperative topical medications and follow-up visits to monitor epithelialization and graft integration. Documentation includes indication, dimensions of the amniotic membrane used (square centimeters), concurrent primary procedure CPT code(s), anatomic site, and any complications or additional procedures performed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no modifier is applicable and standard billing applies for the add-on supply |